Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model (original) (raw)
References
Harris JR, Morrow M, Bonadonna G. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. Lippincott, Philadelphia, 1993, pp 1264-1332 Google Scholar
Maroulakou IG, Anver M, Garrett L, Green JE: Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 91: 11236-11240, 1994 Google Scholar
Parker MG, White R, Hurst H, Needham M, Tilly R: Prostatic steroid binding protein. Isolation and characterization of C3 genes. J Biol Chem 258: 12-15, 1983 Google Scholar
Green JE, Shibata M, Yoshidome K, Liu M, Jorcyk CL, Anver MR, Wigginton JM, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu Z, Calvo A, Couldrey C: The C3(1)/SV40 Tantigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19: 1020-1027, 2000 Google Scholar
Jorcyk CL, Liu M, Shibata M, Maroulakou IG, Komschlies KL, McPhaul MJ, Resau JH, Green JE: Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix. The Prostate 34: 10-22, 1998 Google Scholar
Soares CR, Shibata M, Green JE, Jorcyk CL: Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression. Neoplasia 4: 112-120, 2002 Google Scholar
Pittius CW, Sankaran L, Topper YJ, Henninghausen L: Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol Endocrinol 2: 1027-1232, 1989 Google Scholar
Cato AC, Weinmann J, Mink S, Ponta H, Henderson D, Sonnenberg A: The regulation of expression of mouse mammary tumor virus DNA by steroid hormones and growth factors. J Steroid Biochem 34: 139-143, 1989 Google Scholar
Mietz JA, Unger T, Huibregtse JM, Howly PM: The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T antigen and by HPV-16 E6 oncoprotein. EMBO J 11: 5013-5020, 1992 Google Scholar
Dyson N, Buchkovich K, Whyte P, Harlow E: The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255, 1989 Google Scholar
Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa AP, Chiba I, Takahashi T, Nau MM, Callahan R et al.: Mutations in the p53 gene in primary human breast cancers. Cancer Res 51: 6194-6198, 1991 Google Scholar
Cox LA, Chen G, Lee EY: Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res Treat 32: 19-38, 1994 Google Scholar
Ludlow JW: Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J 7: 866-871, 1993 Google Scholar
Yoshidome K, Shibata M, Maroulakou IG, Liu M, Jorcyk CL, Gold LG, Welch VN, Green JE: Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model (review). Int J Oncol 12: 449-453, 1998 Google Scholar
Yoshidome K, Shibata M, Couldrey C, Korach KS, Green JE: Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptor α expression during tumor progression. Cancer Res 60: 6901-6910, 2000 Google Scholar
Guiochon-Mantel A, Milgrom E. In: Manni A (ed.) Endocrinology of Breast Cancer. Humana, New Jersey, NJ, 1999, pp 245-259 Google Scholar
Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao Q, Deng H, Amenta PS, Fineberg S, Pestell RG, Carrasco N: The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871-878, 2000 Google Scholar
Carrasco N: Iodide transport in the thyroid gland. Biochim Biophys Acta 1154: 65-82, 1993 Google Scholar
Liu M, Von Lintig FC, Liyanage M, Shibata M, Jorcyk CL, Ried T, Boss GR, Green JE: Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene 17: 2403-2411, 1998 Google Scholar
Shibata M, Yoshidome K, Shibata E, Jorcyk CL, Green JE: Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Therapy 1: 1-10, 2000 Google Scholar
Shibata M, Maroulakou IG, Jorcyk CL, Gold L, Ward JM, Green JE: p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res 56: 2998-3003, 1996 Google Scholar
Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ, Green JE: Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40 Tag transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J 18: 2692-2701, 1999 Google Scholar
Wigginton JM, Park JW, Gruys ME, Young HA, Jorcyk CL, Back TC, Brunda MJ, Strieter RM, Ward J, Green JE, Wiltrout RH: Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by Il-12/pulse Il-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis. J Immunol 166: 1156-1168, 2001 Google Scholar
Yokoyama Y, Green JE, Sukhatme VP, Ramakrishnan S: Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model. Cancer Res 60: 4362-4365, 2000 Google Scholar
Welcsh PL, Mankoff DA: Taking up iodide in breast tissue. Nature (Lond.) 406: 688-689, 2000 Google Scholar
Daniels GH, Haber DA: Will radioiodine be useful in treatment of breast cancer? Nat Med 6: 859-860, 2000 Google Scholar
Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H: Decreased expression of estrogen receptor-protein in proliferative preinvasive mammary tumors. Cancer Res 61: 2537-2541, 2001 Google Scholar
Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197-3201, 1998 Google Scholar
Jarvinen TA, Pelto-Huikko M, Holli K, Isola J: Estrogen receptor α is coexpressed with ER β and PR and associated with nodal status, grade, and proliferative rate in breast cancer. Am J Pathol 156: 29-35, 2000 Google Scholar
Speirs V, Parkes AT, Kerin MJ, Walton DS, Carleton PJ, Fox JN, Atkin SL: Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res 59: 525-528, 1999 Google Scholar
Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA: Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer Res 61: 293-302, 2001 Google Scholar
Wang W, Smith R, Burghardt R, Safe SH: 17β-Estradiolmediated growth inhibition ofMDA-MB-468 cell stably transfected with the estrogen receptor: cell cycle effects. Mol Cell Endocrinol 133: 49-62, 1997 Google Scholar
Kordon E, Lanari C, Meiss R, Elizalde P, Charreau E, Pasqualini CD: Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast Cancer Res Treat 17: 33-43, 1990 Google Scholar
Brunner N, Spang-Thomsen M, Cullen K: The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer. Breast Cancer Res Treat 39: 87-92, 1996 Google Scholar
Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 2: 263-271, 1988 Google Scholar
Lapidus RG, Nass SJ, Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mamm Gland Biol Neop 3: 85-94, 1998 Google Scholar
Ross RK, Paganini-Hill A, Wan PC, Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92: 328-332, 2000 Google Scholar
Shi YE, Liu YE, Lippman ME, Dickson RB: Progestins and antiprogestins in mammary tumour growth and metastasis. Hum Reprod 9(suppl. 1): 162-173, 1994 Google Scholar
Sacco MG, Gribaldo L, Barbieri O, Turchi G, Zucchi I, Collatta A, Bagnasco L, Barone D, Montagna C, Villa A, Marafante E, Vezzoni P: Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice. Breast Cancer Res Treat 47: 171-180, 1998 Google Scholar